Zofran (Ondansetron), Zofran ODT (Ondansetron), and Zofran (Ondansetron) Oral Solution are indicated for prevention of postoperative nausea and vomiting (PONV), cancer chemotherapy-induced nausea and vomiting (CINV), and radiotherapy-induced nausea and vomiting (RINV). Zofran (Ondansetron), Zofran ODT (Ondansetron), and Zofran (Ondansetron) Oral Solution can be used for prevention of post-operative nausea and vommiting associated with highly emetogenic cancer chemotherapy,with initial and repeat courses of moderately emetogenic cancer chemotherapy. Only oral Zofran (Ondansetron) is indicated for days 2 and 3 following moderately emetogenic cancer chemotherapy.
Zofran (Ondansetron), Zofran ODT (Ondansetron), and Zofran (Ondansetron) Oral Solution can be used for prevention of post-operative nausea and vommiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen, in patients with high risk of PONV; as with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients where nausea and/or vomiting must be avoided postoperatively,Zofran (Ondansetron) Injection, Zofran (Ondansetron) Tablets, Zofran ODT (Ondansetron) (Orally Disintegrating Tablets), and Zofran (Ondansetron) Oral Solution are recommended even where the incidence of postoperative nausea and/or vomiting is low.
For patients who do not receive prophylactic Zofran (Ondansetron) Injection and experience nausea and/or vomiting postoperatively, Zofran (Ondansetron) Injection may be given to prevent further episodes.
Zofran Side Effects
Phenylketonurics: ZOFRAN ODT (Orally Disintegrating Tablets) contain phenylalanine.
ZOFRAN is contraindicated for patients known to have hypersensitivity to the drug otherwise it may result in Zofran side effects. Zofran side effects like hypersensitivity reactions have been reported in patients who have exhibited hypersensitivity to other selective 5-HT3 receptor antagonists.
Each 4-mg and 8-mg Orally Disintegrating Tablet contains <0.03 mg phenylalanine (a component of aspartame).
The generic alternative is not manufactured by the company that makes the brand product.
The content on this page has been supplied to canadianpharmacyking by an independent third party contracted to provide information for our website.
canadianpharmacyking relies on these third parties to create and maintain this information and cannot guarantee the medical efficacy, accuracy or reliability of the information that has been provided to us.
If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a health professional.
Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy.
We affiliate with other dispensaries that ship product to our customers from the following jurisdictions: Canada, Singapore, New Zealand, Turkey, Mauritius, and United Kingdom.
The items in your order maybe shipped from any of the above jurisdictions.
The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with our authorized dispensaries that procure product through reliable sources.